Financials
- Market Capitalization 348.84 M
- Employee 35
- Founded 2008
- CEO N/A
- Website www.inhibikase.com
- Headquarter Delaware, United States
- FIGI BBG005TP2339
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-4.61
市销率
54.94
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 3142 | AGEN Agenus Inc. - Common Stock | 8.09 USD | +1.25% | -2.29% | +3.06% | +90.80% | 364.22 M USD | ||
| 3143 | DMAC DiaMedica Therapeutics Inc. - Common Stock | 6.75 USD | +4.65% | +1.05% | +2.27% | +27.60% | 364.00 M USD | ||
| 3189 | PALI Palisade Bio, Inc. - Common Stock | 1.99 USD | +1.53% | -6.13% | +3.65% | +17.06% | 346.80 M USD | ||
| 3206 | SABS SAB Biotherapeutics, Inc. - Common Stock | 3.75 USD | +1.35% | -2.85% | -1.32% | +63.04% | 341.20 M USD |